Syncope secondary prevention: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Syncope}} | {{Syncope}} | ||
{{CMG}}; {{AE}} {{Sahar}} | {{CMG}}; {{AE}} {{Sara.Zand}} {{Sahar}} | ||
==Overview== | ==Overview== | ||
Secondary prevention strategies following [[syncope]] include [[ICD implantation]] in [[ventricular arrhythmia]] and avoidance of driving for a specific time based on the guideline. | Secondary prevention strategies following [[syncope]] include [[ICD implantation]] in [[ventricular arrhythmia]] and avoidance of driving for a specific time based on the guideline. | ||
Latest revision as of 15:17, 1 December 2020
|
Syncope Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Syncope secondary prevention On the Web |
|
American Roentgen Ray Society Images of Syncope secondary prevention |
|
Risk calculators and risk factors for Syncope secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Zand, M.D.[2] Sahar Memar Montazerin, M.D.[3]
Overview
Secondary prevention strategies following syncope include ICD implantation in ventricular arrhythmia and avoidance of driving for a specific time based on the guideline.
Secondary Prevention
- Secondary prevention strategies following syncope include ICD implantation in ventricular arrhythmia and avoidance of driving for specific time based on the guideline.[1]
| Condition | Time needed for avoidance of driving after syncope |
|---|---|
| Ortosthasis hypotension | 1 month |
| Vasovagal syncope, no syncope in last year | No restriction |
| Vasovagal syncope, 1-6 syncope per year | 1 month |
| Vasovagal syncope, >6 syncope per year | No permission until resolving the symptoms |
| Situational syncope other than cough syncope | 1 month |
| cough syncope, not treated | No permission |
| cough syncope, treaten with cough suppression | 1 month |
| carotid sinus syncope, not treated | No permission |
| carotid sinus syncope, treated with permanent pacemaker | 1 week |
| Non reflex sinus bradycardia syncope, not treated | No permission |
| Non reflex sinus bradycardia syncope,permanent pace maker implantation | 1 week |
| SVT leading syncope, not treated | No permission |
| SVT leading syncope, arrhythmia suppression with medications | 1 month |
| SVT leading syncope, arrhythmia ablation | 1 week |
| LVEF< 35% , suspected arrhythmic syncope without ICD | No permission |
| LVEF< 35% , suspected arrhythmic syncope with ICD | 3 months |
| LVEF> 35%, structural heart disease,VT or VF leading syncope, not treated | No permission |
| LVEF> 35%, structural heart disease,VT or VF leading syncope, treated with ICD implantation and medications | 3 months |
| Syncope due to VT from RVOT, LVOT regions, untreated | No permission |
| Syncope due to VT from RVOT, LVOT regions , treated with ICD implantation and medications | 3 months |
| Syncope of undetermined etiology | 1 month |
References
- ↑ Shen, Win-Kuang; Sheldon, Robert S.; Benditt, David G.; Cohen, Mitchell I.; Forman, Daniel E.; Goldberger, Zachary D.; Grubb, Blair P.; Hamdan, Mohamed H.; Krahn, Andrew D.; Link, Mark S.; Olshansky, Brian; Raj, Satish R.; Sandhu, Roopinder Kaur; Sorajja, Dan; Sun, Benjamin C.; Yancy, Clyde W. (2017). "2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society". Circulation. 136 (5). doi:10.1161/CIR.0000000000000499. ISSN 0009-7322.